🇺🇸 FDA
Patent

US 8853247

Oligomer-nitroimidazole anti-infective conjugates

granted A61KA61K47/60A61P

Quick answer

US patent 8853247 (Oligomer-nitroimidazole anti-infective conjugates) held by Nektar Therapeutics expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K47/60, A61P, A61P31/00, A61P31/04